MBF Therapeutics Inc.
Ambler, PA
- UEI
- MDBMP1F2NHL6
- CAGE
- 7SUJ8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 640 Woodbrook Dr, Ambler, PA 19002, USA
- Website
- mbftherapeutics.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sttr phase i: protective t cell vaccine for sars COV-2 (covid-19) | Division of Industrial Innovation | $256,000 |
Quick answers
What is MBF Therapeutics Inc.'s UEI?
MBF Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MDBMP1F2NHL6.
What is MBF Therapeutics Inc.'s CAGE code?
MBF Therapeutics Inc.'s CAGE code is 7SUJ8.
What is MBF Therapeutics Inc.'s primary NAICS code?
MBF Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is MBF Therapeutics Inc. located?
MBF Therapeutics Inc.'s physical address in SAM.gov is 640 Woodbrook Dr, Ambler, PA 19002, USA.
Is MBF Therapeutics Inc. registered in SAM.gov?
Yes. MBF Therapeutics Inc.'s SAM.gov registration is active through December 8, 2026.
What is MBF Therapeutics Inc.'s most recent federal award?
MBF Therapeutics Inc.'s most recent federal grant award is Sttr phase i: protective t cell vaccine for sars COV-2 (covid-19) (2131876), from Division of Industrial Innovation, on January 1, 2022.
On GovTribe
See MBF Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors